Clinical Trials
4 trialsNCT00453362 2017-03-31
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Genentech, Inc.
Phase 1/2 Completed
NCT01480583 2016-07-13
GRABM-B
Angiochem Inc
Phase 2 Completed
NCT00847509 2013-09-27
FLT101
Siemens Molecular Imaging
Phase NA Completed
NCT00553748 2008-07-03
Phase I, Open Label, Single Center Safety Study of [F-18]FLT
Siemens Molecular Imaging
Phase 1 Completed